Published in Pathog Dis on September 10, 2013
LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague. Infect Immun (2014) 0.79
Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague. Vaccine (2015) 0.76
Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague. Vaccine (2016) 0.75
Temperature-dependence of yadBC phenotypes in Yersinia pestis. Microbiology (2013) 0.75
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli. Anal Biochem (1976) 5.79
The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev (1998) 5.78
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med (2008) 5.42
Secretion of beta-lactamase requires the carboxy end of the protein. Cell (1980) 5.03
Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis (1975) 4.51
Mucosal vaccines: the promise and the challenge. Nat Rev Immunol (2006) 4.41
Yersinia type III secretion: send in the effectors. J Cell Biol (2002) 3.04
Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect Immun (1997) 2.81
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine (1998) 2.75
TH1-TH2: a procrustean paradigm. Nat Immunol (2003) 2.44
Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague. Infect Immun (1990) 2.30
Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect Immun (2002) 2.25
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun (1996) 2.17
A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol (1995) 2.16
Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun (2002) 2.16
Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun (1981) 2.15
NEW ANTIGENIC COMPONENT OF PASTEURELLA PESTIS FORMED UNDER SPECIFIED CONDITIONS OF pH AND TEMPERATURE. J Bacteriol (1961) 2.13
An antigen determining virulence in Pasteurella pestis. Nature (1956) 2.13
Vaccination against bubonic and pneumonic plague. Vaccine (2001) 2.08
Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med (1996) 2.04
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun (1995) 2.04
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine (1995) 2.03
Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhesin YadA. J Bacteriol (2003) 1.96
Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin Exp Immunol (1985) 1.88
An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. Bull World Health Organ (1960) 1.86
Analysis of the pesticin receptor from Yersinia pestis: role in iron-deficient growth and possible regulation by its siderophore. J Bacteriol (1995) 1.85
Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. Dev Biol Stand (1983) 1.64
Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol (2003) 1.56
Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin. Infect Immun (1986) 1.43
Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A (2008) 1.43
A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine (2004) 1.38
The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun (2010) 1.32
Yersinia pestis caf1 variants and the limits of plague vaccine protection. Infect Immun (2008) 1.32
Bacterial infectious disease control by vaccine development. J Clin Invest (2002) 1.30
Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun (1999) 1.30
Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol (2007) 1.29
Biochemical and cytochemical evidence for the polar concentration of periplasmic enzymes in a "minicell" strain of Escherichia coli. J Bacteriol (1970) 1.25
Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun (2008) 1.23
Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent delta cya delta crp S. typhimurium. Res Microbiol (1991) 1.19
Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb Pathog (1997) 1.18
Illicit secretion of a cytoplasmic protein into the periplasm of Escherichia coli requires a signal peptide plus a portion of the cognate secreted protein. Demarcation of the critical region of the mature protein. J Biol Chem (1989) 1.15
Plague: from natural disease to bioterrorism. Proc (Bayl Univ Med Cent) (2005) 1.12
A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect Immun (2008) 1.12
Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infect Immun (1997) 1.08
yadBC of Yersinia pestis, a new virulence determinant for bubonic plague. Infect Immun (2007) 1.08
Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine (2003) 1.05
Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice. Clin Vaccine Immunol (2010) 1.04
Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen. PLoS One (2010) 1.04
Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect Immun (2008) 1.01
Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis). Experientia (1984) 1.01
Pneumonic plague--Arizona, 1992. MMWR Morb Mortal Wkly Rep (1992) 0.99
Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Adv Exp Med Biol (2007) 0.94
Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Vaccine (2010) 0.91
Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. Vaccine (2004) 0.90
Amino acid and structural variability of Yersinia pestis LcrV protein. Infect Genet Evol (2009) 0.90
Chronic infections in laboratory rodents from inoculation of nonencapsulated plague bacilli (Yersinia pestis). Experientia (1983) 0.90
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa. Infect Immun (2010) 0.89
Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence. Int Immunol (1999) 0.89
Yersinia pestis YadC: a novel vaccine candidate against plague. Adv Exp Med Biol (2007) 0.88
Human plague in 2000 and 2001. Wkly Epidemiol Rec (2003) 0.87
Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges. Adv Prev Med (2011) 0.86
Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis. Microb Pathog (2012) 0.82
Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA. Vaccine (2010) 0.81
A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains. Infect Immun (2013) 0.79
Salmonella-based plague vaccines for bioterrorism. J Microbiol Immunol Infect (2006) 0.78
Partial Retraction: yadBC of Yersinia pestis, a new virulence determinant for bubonic plague. Infect Immun (2013) 0.76
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 3.53
Fatty acid production in genetically modified cyanobacteria. Proc Natl Acad Sci U S A (2011) 2.77
Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect Immun (2002) 2.25
Identification of pathogen-specific and conserved genes expressed in vivo by an avian pathogenic Escherichia coli strain. Proc Natl Acad Sci U S A (2002) 2.12
NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cells. Nat Immunol (2012) 1.62
Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol (2003) 1.56
Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo. Infect Immun (2008) 1.48
Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A (2008) 1.43
Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci U S A (2008) 1.43
Sequencing and functional annotation of avian pathogenic Escherichia coli serogroup O78 strains reveal the evolution of E. coli lineages pathogenic for poultry via distinct mechanisms. Infect Immun (2012) 1.37
Role of virulence factors in resistance of avian pathogenic Escherichia coli to serum and in pathogenicity. Infect Immun (2003) 1.36
Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium. Infect Immun (2011) 1.30
Recombinant attenuated Salmonella enterica serovar typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin Vaccine Immunol (2008) 1.23
Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun (2008) 1.23
New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit Rev Immunol (2010) 1.20
Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun (2002) 1.18
Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J Bacteriol (2002) 1.17
Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J Immunol (2011) 1.15
Contribution of the SitABCD, MntH, and FeoB metal transporters to the virulence of avian pathogenic Escherichia coli O78 strain chi7122. Infect Immun (2007) 1.14
Nickel-inducible lysis system in Synechocystis sp. PCC 6803. Proc Natl Acad Sci U S A (2009) 1.13
A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect Immun (2006) 1.12
A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect Immun (2008) 1.12
Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome. Appl Environ Microbiol (2008) 1.11
The introduction of new vaccines into developing countries. IV: Global Access Strategies. Vaccine (2007) 1.11
SdiA, an N-acylhomoserine lactone receptor, becomes active during the transit of Salmonella enterica through the gastrointestinal tract of turtles. PLoS One (2008) 1.11
Inactivation of the pst system reduces the virulence of an avian pathogenic Escherichia coli O78 strain. Infect Immun (2005) 1.09
PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae. Infect Immun (2009) 1.09
Full sequence and comparative analysis of the plasmid pAPEC-1 of avian pathogenic E. coli chi7122 (O78:K80:H9). PLoS One (2009) 1.07
CO2-limitation-inducible Green Recovery of fatty acids from cyanobacterial biomass. Proc Natl Acad Sci U S A (2011) 1.07
Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages. Infect Immun (2003) 1.07
Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen. PLoS One (2010) 1.04
Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun (2010) 1.04
Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice. Clin Vaccine Immunol (2010) 1.04
Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium. J Bacteriol (2008) 1.03
The Salmonella Pathogenicity Island (SPI) 1 contributes more than SPI2 to the colonization of the chicken by Salmonella enterica serovar Typhimurium. BMC Microbiol (2009) 1.03
Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect Immun (2010) 1.02
Contribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infections. Proc Natl Acad Sci U S A (2013) 1.02
Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect Immun (2006) 1.02
The role of relA and spoT in Yersinia pestis KIM5 pathogenicity. PLoS One (2009) 1.01
Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect Immun (2008) 1.01
Characterization of the contribution to virulence of three large plasmids of avian pathogenic Escherichia coli chi7122 (O78:K80:H9). Infect Immun (2010) 0.99
Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen. Infect Immun (2009) 0.98
Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague. Infect Immun (2010) 0.98
Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model. Vaccine (2011) 0.98
Selective capture of Salmonella enterica serovar typhi genes expressed in macrophages that are absent from the Salmonella enterica serovar Typhimurium genome. Infect Immun (2005) 0.97
Construction of transcriptional and translational lacZ gene reporter plasmids for use in Streptococcus mutans. J Microbiol Methods (2002) 0.96
Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers. Clin Vaccine Immunol (2010) 0.96
New technologies in developing recombinant attenuated Salmonella vaccine vectors. Microb Pathog (2012) 0.95
New insights into the bacterial fitness-associated mechanisms revealed by the characterization of large plasmids of an avian pathogenic E. coli. PLoS One (2012) 0.95
Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines. Infect Immun (2010) 0.94
Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Vaccine (2010) 0.94
Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Adv Exp Med Biol (2007) 0.94
A dual-signal regulatory circuit activates transcription of a set of divergent operons in Salmonella typhimurium. Proc Natl Acad Sci U S A (2008) 0.93
Turning self-destructing Salmonella into a universal DNA vaccine delivery platform. Proc Natl Acad Sci U S A (2012) 0.93
The Campylobacter jejuni Dps homologue is important for in vitro biofilm formation and cecal colonization of poultry and may serve as a protective antigen for vaccination. Clin Vaccine Immunol (2012) 0.92
Comparative genome analysis of the high pathogenicity Salmonella Typhimurium strain UK-1. PLoS One (2012) 0.92
Phosphate groups of lipid A are essential for Salmonella enterica serovar Typhimurium virulence and affect innate and adaptive immunity. Infect Immun (2012) 0.91
Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Vaccine (2010) 0.91
Export of extracellular polysaccharides modulates adherence of the Cyanobacterium synechocystis. PLoS One (2013) 0.90
Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect Immun (2010) 0.89
Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium. Infect Immun (2004) 0.89
Thermorecovery of cyanobacterial fatty acids at elevated temperatures. J Biotechnol (2012) 0.89
A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine. J Virol (2009) 0.88
Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Vaccine (2011) 0.88
A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine (2011) 0.88
The aspartate-semialdehyde dehydrogenase of Edwardsiella ictaluri and its use as balanced-lethal system in fish vaccinology. PLoS One (2010) 0.88
Complete genome sequence of the universal killer Salmonella enterica Serovar Typhimurium UK-1 (ATCC 68169). J Bacteriol (2011) 0.87
Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. Vaccine (2010) 0.87
Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Infect Immun (2010) 0.87
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA. Vaccine (2013) 0.85
Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant. Infect Immun (2011) 0.85
Differential effect of auxotrophies on the release of macromolecules by Salmonella enterica vaccine strains. FEMS Microbiol Lett (2006) 0.85
Modulation of the regulatory activity of bacterial two-component systems by SlyA. J Biol Chem (2008) 0.84
Biogenesis of Yersinia pestis PsaA in recombinant attenuated Salmonella Typhimurium vaccine (RASV) strain. FEMS Microbiol Lett (2009) 0.84
Mechanisms of intrinsic resistance to antimicrobial peptides of Edwardsiella ictaluri and its influence on fish gut inflammation and virulence. Microbiology (2013) 0.84
Immunogenicity of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine strains carrying a gene that encodes Eimeria tenella antigen SO7. Infect Immun (2008) 0.84
The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine. Infect Immun (2012) 0.83
Virulence attenuation and live vaccine potential of aroA, crp cdt cya, and plasmid-cured mutants of Salmonella enterica serovar Abortusovis in mice and sheep. Infect Immun (2005) 0.83
Fur-regulated iron uptake system of Edwardsiella ictaluri and its influence on pathogenesis and immunogenicity in the catfish host. Infect Immun (2012) 0.83
Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis. Microb Pathog (2012) 0.82
Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis. Infect Immun (2011) 0.82
Improving Salmonella vector with rec mutation to stabilize the DNA cargoes. BMC Microbiol (2011) 0.82
Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophages. Cytokine (2011) 0.82
Developing live vaccines against plague. J Infect Dev Ctries (2011) 0.81
Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA. Vaccine (2010) 0.81
Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi. J Infect Dev Ctries (2008) 0.80
Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system. Infect Immun (2011) 0.80